|
|
||||||||
From the Department of Medicine (Dr. Watson), University of Toronto, and Department of Scientific Affairs (Dr. Babul), Furdue Frederick, Pickering, Ontario, Canada.
Address correspondence and reprint requests to Dr. C. Peter N. Watson, 1 Sir Williams Lane, Toronto, Ontario, Canada M9A 1T8
Objective Although opioid analgesics are used in the management of neuropathic pain syndromes, evidence of their efficacy remains to be established. We evaluated the clinical efficacy and safety of oxycodone in neuropathic pain using postherpetic neuralgia as a model.
Methods Patients with postherpetic neuralgia of at least moderate intensity were randomized to controlled-release oxycodone 10 mg or placebo every 12 hours, each for 4 weeks, using a double-blind, crossover design. The dose was increased weekly up to a possible maximum of 30 mg every 12 hours. Pain intensity and pain relief were assessed daily, and steady (ongoing) pain, brief (paroxysmal) pain, skin pain (allo-dynia), and pain relief were recorded at weekly visits. Clinical effectiveness, disability, and treatment preference were also assessed.
Results Fifty patients were enrolled and 38 completed the study (16 men, 22 women, age 70± 2 11 years, onset of postherpetic neuralgia 31± 2 29 months, duration of pain 18 ± 5 hours per day). The oxycodone dose during the final week was 45 ±5 17 mg per day. Compared with placebo, oxycodone resulted in pain relief (2.9±2 1.2 versus 1.8 ± 1.1, p = 0.0001) and reductions in steady pain (34 ± 26 versus 55 ± 27 mm, p = 0.0001), allodynia (32 ±2 26 versus 50 ±2 30 mm, p = 0.0004), and paroxysmal spontaneous pain (22 ± 24 versus 42 ± 32 mm, p = 0.0001). Global effectiveness, disability, and masked patient preference all showed superior scores with oxycodone relative to placebo (1.8 ±.11 versus 0.7 ± 1.0, p = 0.0001; 0.3 ± 0.8 versus 0.7 ± 1.0, p = 0.041; 67% versus 11%, p = 0.001, respectively).
Conclusions Controlled-release oxycodone is an effective analgesic for the management of steady pain, paroxysmal spontaneous pain, and allodynia, which frequently characterize postherpetic neuralgia.
Supported by a research grant from Purdue Frederick.
Received October 15, 1997. Accepted in final form January 23, 1998.
This article has been cited by other articles:
![]() |
J. Devulder, A. Jacobs, U. Richarz, and H. Wiggett Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant pain Br. J. Anaesth., October 1, 2009; 103(4): 576 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Whitley A 70-Year-Old Woman With Shingles: Review of Herpes Zoster JAMA, July 1, 2009; 302(1): 73 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Argoff and D. I. Silvershein A Comparison of Long- and Short-Acting Opioids for the Treatment of Chronic Noncancer Pain: Tailoring Therapy to Meet Patient Needs Mayo Clin. Proc., July 1, 2009; 84(7): 602 - 612. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Galluzzi Managing Herpes Zoster and Postherpetic Neuralgia J Am Osteopath Assoc, June 1, 2009; 109(6_suppl_2): S7 - S12. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Van Zee The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy Am J Public Health, February 1, 2009; 99(2): 221 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Gajraj Pregabalin: Its Pharmacology and Use in Pain Management Anesth. Analg., December 1, 2007; 105(6): 1805 - 1815. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Kimberlin and R. J. Whitley Varicella-Zoster Vaccine for the Prevention of Herpes Zoster N. Engl. J. Med., March 29, 2007; 356(13): 1338 - 1343. [Full Text] [PDF] |
||||
![]() |
M. D. Hix Pain Management in Elderly Patients Journal of Pharmacy Practice, February 1, 2007; 20(1): 49 - 63. [Abstract] [PDF] |
||||
![]() |
K. Lemberg, V. K. Kontinen, K. Viljakka, I. Kylanlahti, J. Yli-Kauhaluoma, and E. Kalso Morphine, oxycodone, methadone and its enantiomers in different models of nociception in the rat. Anesth. Analg., June 1, 2006; 102(6): 1768 - 1774. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Furlan, J. A. Sandoval, A. Mailis-Gagnon, and E. Tunks Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. Can. Med. Assoc. J., May 23, 2006; 174(11): 1589 - 1594. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Deshpande, R. R. Holden, and I. Gilron The impact of therapy on quality of life and mood in neuropathic pain: what is the effect of pain reduction? Anesth. Analg., May 1, 2006; 102(5): 1473 - 1479. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sinatra Opioid Analgesics in Primary Care: Challenges and New Advances in the Management of Noncancer Pain J Am Board Fam Med, March 1, 2006; 19(2): 165 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kalita, A. Vajpayee, and U.K. Misra Comparison of prednisolone with piroxicam in complex regional pain syndrome following stroke: a randomized controlled trial QJM, February 1, 2006; 99(2): 89 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Rowbotham Mechanisms of neuropathic pain and their implications for the design of clinical trials Neurology, December 29, 2005; 65(12_suppl_4): S66 - S73. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Irving Contemporary assessment and management of neuropathic pain Neurology, June 28, 2005; 64(12_suppl_3): S21 - S27. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Eisenberg, E. D. McNicol, and D. B. Carr Efficacy and Safety of Opioid Agonists in the Treatment of Neuropathic Pain of Nonmalignant Origin: Systematic Review and Meta-analysis of Randomized Controlled Trials JAMA, June 22, 2005; 293(24): 3043 - 3052. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Scott and M. J. Kothari Evaluating the Patient with Peripheral Nervous System Complaints J Am Osteopath Assoc, February 1, 2005; 105(2): 71 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Rubey Treatment of chronic pain in persons with dementia: An overview American Journal of Alzheimer's Disease and Other Dementias, January 1, 2005; 20(1): 12 - 20. [Abstract] [PDF] |
||||
![]() |
R. M. Dubinsky, H. Kabbani, Z. El-Chami, C. Boutwell, and H. Ali Practice Parameter: Treatment of postherpetic neuralgia: An evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology, September 28, 2004; 63(6): 959 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lussier, A. G. Huskey, and R. K. Portenoy Adjuvant Analgesics in Cancer Pain Management Oncologist, September 1, 2004; 9(5): 571 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Lim and P. Y. Takahashi 80-Year-Old Man With Fever and Ear Pain Mayo Clin. Proc., August 1, 2004; 79(8): 1055 - 1058. [PDF] |
||||
![]() |
B. Lalovic, B. Phillips, L. L. Risler, W. Howald, and D. D. Shen QUANTITATIVE CONTRIBUTION OF CYP2D6 AND CYP3A TO OXYCODONE METABOLISM IN HUMAN LIVER AND INTESTINAL MICROSOMES Drug Metab. Dispos., April 1, 2004; 32(4): 447 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
E J Hall and N P Sykes Analgesia for patients with advanced disease: I Postgrad. Med. J., March 1, 2004; 80(941): 148 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Ballantyne Chronic Pain Following Treatment for Cancer: The Role of Opioids Oncologist, December 1, 2003; 8(6): 567 - 575. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Ballantyne and J. Mao Opioid Therapy for Chronic Pain N. Engl. J. Med., November 13, 2003; 349(20): 1943 - 1953. [Full Text] [PDF] |
||||
![]() |
R. H. Dworkin, M. Backonja, M. C. Rowbotham, R. R. Allen, C. R. Argoff, G. J. Bennett, M. C. Bushnell, J. T. Farrar, B. S. Galer, J. A. Haythornthwaite, et al. Advances in Neuropathic Pain: Diagnosis, Mechanisms, and Treatment Recommendations Arch Neurol, November 1, 2003; 60(11): 1524 - 1534. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S Morley, J. Bridson, T. P Nash, J. B Miles, S. White, and M. K Makin Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial Palliative Medicine, October 1, 2003; 17(7): 576 - 587. [Abstract] [PDF] |
||||
![]() |
J. Gardner-Nix Principles of opioid use in chronic noncancer pain Can. Med. Assoc. J., July 8, 2003; 169(1): 38 - 43. [Full Text] [PDF] |
||||
![]() |
R.H. Dworkin, A.E. Corbin, J.P. Young Jr., U. Sharma, L. LaMoreaux, H. Bockbrader, E.A. Garofalo, and R.M. Poole Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial Neurology, April 22, 2003; 60(8): 1274 - 1283. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Rowbotham, L. Twilling, P. S. Davies, L. Reisner, K. Taylor, and D. Mohr Oral Opioid Therapy for Chronic Peripheral and Central Neuropathic Pain N. Engl. J. Med., March 27, 2003; 348(13): 1223 - 1232. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Mendell and Z. Sahenk Painful Sensory Neuropathy N. Engl. J. Med., March 27, 2003; 348(13): 1243 - 1255. [Full Text] [PDF] |
||||
![]() |
D. W. Zochodne and M. B. Max An old acquaintance: Opioids in neuropathic pain Neurology, March 25, 2003; 60(6): 894 - 895. [Full Text] [PDF] |
||||
![]() |
J. S. Gimbel, P. Richards, and R. K. Portenoy Controlled-release oxycodone for pain in diabetic neuropathy: A randomized controlled trial Neurology, March 25, 2003; 60(6): 927 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Manfredi, S. N. Raja, J. A. Haythornthwaite, and M. B. Max Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial Neurology, March 25, 2003; 60(6): 1052 - 1053. [Full Text] [PDF] |
||||
![]() |
S. N. Raja, J. A. Haythornthwaite, M. Pappagallo, M. R. Clark, T. G. Travison, S. Sabeen, R. M. Royall, and M. B. Max Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial Neurology, October 8, 2002; 59(7): 1015 - 1021. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Opstelten, J. W Mauritz, N. J de Wit, A. J. van Wijck, W. A. Stalman, and G. A van Essen Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database Fam. Pract., October 1, 2002; 19(5): 471 - 475. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Gnann Jr. and R. J. Whitley Herpes Zoster N. Engl. J. Med., August 1, 2002; 347(5): 340 - 346. [Full Text] [PDF] |
||||
![]() |
H. Harke, P. Gretenkort, H. U. Ladleif, P. Koester, and S. Rahman Spinal Cord Stimulation in Postherpetic Neuralgia and in Acute Herpes Zoster Pain Anesth. Analg., March 1, 2002; 94(3): 694 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Attal, F. Guirimand, L. Brasseur, V. Gaude, M. Chauvin, and D. Bouhassira Effects of IV morphine in central pain: A randomized placebo-controlled study Neurology, February 26, 2002; 58(4): 554 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-J. Collett Chronic opioid therapy for non-cancer pain Br. J. Anaesth., July 1, 2001; 87(1): 133 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Allan, H. Hays, N.-H. Jensen, B. L. P. de Waroux, M. Bolt, R. Donald, and E. Kalso Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain BMJ, May 12, 2001; 322(7295): 1154 - 1154. [Abstract] [Full Text] |
||||
![]() |
W. M. Landau, S. H. Sindrup, and T. S. Jensen Pharmacologic treatment of pain in polyneuropathy Neurology, April 24, 2001; 56(8): 1121 - 1121. [Full Text] [PDF] |
||||
![]() |
H. Harke, P. Gretenkort, H. U. Ladleif, S. Rahman, and O. Harke The Response of Neuropathic Pain and Pain in Complex Regional Pain Syndrome I to Carbamazepine and Sustained-Release Morphine in Patients Pretreated with Spinal Cord Stimulation: A Double-Blinded Randomized Study Anesth. Analg., February 1, 2001; 92(2): 488 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
Drug treatment of neuropathic pain DTB, December 1, 2000; 38(12): 89 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. N. Watson A New Treatment for Postherpetic Neuralgia N. Engl. J. Med., November 23, 2000; 343(21): 1563 - 1565. [Full Text] |
||||
![]() |
A. Carver, R. Payne, K. Foley, R. H. Dworkin, B. S. Galer, M. C. Rowbotham, A. A. Gershon, R. T. Perkin, G. Breton, F. Bricaire, et al. Herpes Zoster N. Engl. J. Med., July 20, 2000; 343(3): 221 - 223. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |